The impact of chromosomal fusions on 3D genome
The influence of chromosomal fusions on 3D genome folding and recombination within the germ line
The spatial folding of chromosomes contained in the nucleus has regulatory results on gene expression, but the influence of genome reshuffling on this group stays unclear. Right here, we make the most of chromosome conformation seize together with single-nucleotide polymorphism (SNP) genotyping and evaluation of crossover occasions to review how the higher-order chromatin group and recombination landscapes are affected by chromosomal fusions within the mammalian germ line.
We exhibit that chromosomal fusions alter the nuclear structure throughout meiosis, together with an elevated price of heterologous interactions in main spermatocytes, and alterations in each chromosome synapsis and axis size.
These disturbances in topology have been related to modifications in genomic landscapes of recombination, leading to detectable genomic footprints. General, we present that chromosomal fusions influence the dynamic genome topology of germ cells in two methods: (i) altering chromosomal nuclear occupancy and synapsis, and (ii) reshaping landscapes of recombination.
Profiles of immune cell infiltration and immune-related genes within the tumor microenvironment of HNSCC with or with out HPV an infection
Head and neck squamous cell carcinoma (HNSCC) are the sixth commonest most cancers sort on this planet. Human papillomavirus (HPV) an infection is an rising threat issue for HNSCC. Immune infiltration of HNSCC is linked to therapeutic outcomes. This text aimed to determine whether or not variations in HPV standing have an effect on immune infiltration, molecular mechanism, and the way these outcomes fluctuate in HNSCC sufferers.
We investigated the tumor-infiltrating immune cells (TIICs) and immune-related gene variations between HPV (+) and HPV (-) HNSCC. The gene expression quantification information of HNSCC and their medical data have been obtain from the TCGA database. Immune-related genes have been linked to the ImmPort platform.
After analyzed of 22 TIICs within the HNSCC tumor atmosphere by CIBERSORT and additional evaluation, decrease reminiscence B cell and better T cell regulatory have been related with higher HPV (-) HNSCC end result, increased activated reminiscence CD4 T cell, increased T cell regulatory, and decrease activated NK cell have been linked with higher HPV (+) consequence.
We lastly acquired 5 types of immune genes (CAMP, EDNRB, NTS, CXCL9, LHB) related to HNSCC development. Larger expressions of CAMP, EDNRB, and NTS have been related to elevated total survival in HPV (-) sufferers. Larger expression of CXCL9 and decrease expression of LHB contributed to elevated total survival of HPV (+) sufferers.
There are typically discrepancies within the cell construction of TIICs and immune-related genes in HPV (-) and HPV (+) HNSCC. These variances are usually too essential for the therapeutic end result of the affected person and the event of the tumor. In particular, our pattern established these candidate immune cells and immune-related genes as candidate reservoirs for additional researches.
ALK kinase inhibitor-1 |
|||
T6409-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: ALK kinase inhibitor-1 |
ALK kinase inhibitor-1 |
|||
T6409-1g | TargetMol Chemicals | 1g | Ask for price |
Description: ALK kinase inhibitor-1 |
ALK kinase inhibitor-1 |
|||
T6409-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: ALK kinase inhibitor-1 |
ALK kinase inhibitor-1 |
|||
T6409-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: ALK kinase inhibitor-1 |
ALK kinase inhibitor-1 |
|||
T6409-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: ALK kinase inhibitor-1 |
TAO Kinase inhibitor 1 |
|||
HY-112136 | MedChemExpress | 50mg | EUR 530.31 |
Description: TAO Kinase inhibitor 1 (compound 43) is a selective, ATP-competitive thousand-and-one amino acid kinases (TAOK) inhibitor with IC50s of 11 to 15 nM for TAOK1 and 2, respectively. TAO Kinase inhibitor 1 delays mitosis and induces mitotic cell death[1]. |
TAO Kinase inhibitor 1 |
|||
MBS5755584-10mg | MyBiosource | 10mg | EUR 195 |
TAO Kinase inhibitor 1 |
|||
MBS5755584-25mg | MyBiosource | 25mg | EUR 300 |
TAO Kinase inhibitor 1 |
|||
MBS5755584-2mg | MyBiosource | 2mg | EUR 145 |
TAO Kinase inhibitor 1 |
|||
MBS5755584-50mg | MyBiosource | 50mg | EUR 460 |
TAO Kinase inhibitor 1 |
|||
MBS5755584-5mg | MyBiosource | 5mg | EUR 160 |
TAO Kinase inhibitor 1 |
|||
T16987-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-1g | TargetMol Chemicals | 1g | Ask for price |
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: TAO Kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
HY-100556 | MedChemExpress | 10 mg | EUR 1060.62 |
Description: Tie2 kinase inhibitor 1 (compound 5) is a potent, selective Tie2 kinase inhibitor with an IC50 of 250 nM[1]. Tie2 kinase inhibitor 1 has anti-cancer activity[2]. |
RIP1 kinase inhibitor 1 |
|||
HY-111409 | MedChemExpress | 10 mg | EUR 2056.31 |
Description: RIP1 kinase inhibitor 1 (compound 22) is a highly potent, orally available, and brain-penetrating RIP1 kinase inhibitor (pKi=9.04)[1]. |
RIP2 kinase inhibitor 1 |
|||
HY-133014 | MedChemExpress | Get quote | Ask for price |
Description: RIP2 kinase inhibitor 1 (compound 11) is a potent and selective receptor interacting protein 2 (RIP2) kinase inhibitor with an IC50 of 0.03 μM for RIP2 FP. RIP2 kinase inhibitor 1 is used for autoinflammatory disorders[1]. |
EGFR kinase inhibitor 1 |
|||
HY-143246 | MedChemExpress | Get quote | Ask for price |
Description: EGFR kinase inhibitor 1 is a potent EGFR inhibitor with IC50s of 37, 1.7, >300 nM for WT, l885R/T790M, L858R/T790M/C797S, respectively. EGFR kinase inhibitor 1 induces apoptosis and cell cycle arrest at G0/G1-phase. EGFR kinase inhibitor 1 inhibits the cell motility. EGFR kinase inhibitor 1 shows antiproliferative and anti-tumor activity[1]. |
Tpl2 Kinase Inhibitor 1 |
|||
HY-12358 | MedChemExpress | 1 mg | EUR 1190.49 |
Description: Tpl2 Kinase Inhibitor 1 is a 3-pyridylmethylamino analog, and is a selective Tpl2 inhibitor (IC50=50 nM). Tpl2 consists of COT kinase and MAP3K8. Tpl2 Kinase Inhibitor 1 plays an important role in the regulation of the inflammatory response and the progression of some cancers[1][2]. |
RIP1 kinase inhibitor 1 |
|||
MBS5767491-100mg | MyBiosource | 100mg | EUR 3280 |
RIP1 kinase inhibitor 1 |
|||
MBS5767491-50mg | MyBiosource | 50mg | EUR 2185 |
RIP1 kinase inhibitor 1 |
|||
MBS5767491-5x100mg | MyBiosource | 5x100mg | EUR 14615 |
RIP2 kinase inhibitor 1 |
|||
MBS5767493-5mg | MyBiosource | 5mg | EUR 915 |
RIP2 kinase inhibitor 1 |
|||
MBS5767493-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
RIP2 kinase inhibitor 1 |
|||
MBS3841571-10mg | MyBiosource | 10mg | EUR 615 |
RIP2 kinase inhibitor 1 |
|||
MBS3841571-50mg | MyBiosource | 50mg | EUR 1675 |
RIP2 kinase inhibitor 1 |
|||
MBS3841571-5mg | MyBiosource | 5mg | EUR 430 |
RIP2 kinase inhibitor 1 |
|||
MBS3841571-5x50mg | MyBiosource | 5x50mg | EUR 7520 |
RIP1 kinase inhibitor 1 |
|||
MBS3844604-10mg | MyBiosource | 10mg | EUR 1905 |
RIP1 kinase inhibitor 1 |
|||
MBS3844604-1mg | MyBiosource | 1mg | EUR 430 |
RIP1 kinase inhibitor 1 |
|||
MBS3844604-5mg | MyBiosource | 5mg | EUR 1165 |
RIP1 kinase inhibitor 1 |
|||
MBS3844604-5x10mg | MyBiosource | 5x10mg | EUR 8565 |
Tpl2 Kinase Inhibitor 1 |
|||
MBS5755649-25mg | MyBiosource | 25mg | EUR 1610 |
Tpl2 Kinase Inhibitor 1 |
|||
MBS5755649-5x25mg | MyBiosource | 5x25mg | EUR 7095 |
RIP1 kinase inhibitor 1 |
|||
T12725-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-1g | TargetMol Chemicals | 1g | Ask for price |
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: RIP1 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-1g | TargetMol Chemicals | 1g | Ask for price |
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: RIP2 kinase inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Tpl2 Kinase Inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Tie2 kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-1g | TargetMol Chemicals | 1g | Ask for price |
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: EGFR kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
HY-143295 | MedChemExpress | Get quote | Ask for price |
Description: Pim-1 kinase inhibitor 1 is a Pim-1 kinase inhibitor with an IC50 of 0.11 μM for Pim-1 kinase. Pim-1 kinase inhibitor 1 shows anticancer activity to several cancer cell lines by promotes cell apoptosis. Pim-1 kinase inhibitor 1 can be used for the research of cancer[1]. |
Pim-1 kinase inhibitor 1 |
|||
T60972-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Pim-1 kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
HY-111507 | MedChemExpress | 10 mg | EUR 1785.74 |
Description: PDGFRα kinase inhibitor 1 is a highly selective type II PDGFRα kinase inhibitor with IC50s of 132 nM and 6115 nM for PDGFRα and PDGFRβ, respectively[1]. |
PDGFRα kinase inhibitor 1 |
|||
T12396-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-1g | TargetMol Chemicals | 1g | Ask for price |
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: PDGFRα kinase inhibitor 1 |
PDGFRalpha kinase inhibitor 1 |
|||
MBS5753656-100mg | MyBiosource | 100mg | EUR 2840 |
PDGFRalpha kinase inhibitor 1 |
|||
MBS5753656-25mg | MyBiosource | 25mg | EUR 1170 |
PDGFRalpha kinase inhibitor 1 |
|||
MBS5753656-50mg | MyBiosource | 50mg | EUR 1905 |
PDGFRalpha kinase inhibitor 1 |
|||
MBS5753656-5x100mg | MyBiosource | 5x100mg | EUR 12620 |
PDGFRalpha kinase inhibitor 1 |
|||
MBS3844085-100mg | MyBiosource | 100mg | EUR 3755 |
PDGFRalpha kinase inhibitor 1 |
|||
MBS3844085-10mg | MyBiosource | 10mg | EUR 685 |
PDGFRalpha kinase inhibitor 1 |
|||
MBS3844085-50mg | MyBiosource | 50mg | EUR 1915 |
PDGFRalpha kinase inhibitor 1 |
|||
MBS3844085-5mg | MyBiosource | 5mg | EUR 425 |
PDGFRalpha kinase inhibitor 1 |
|||
MBS3844085-5x100mg | MyBiosource | 5x100mg | EUR 16900 |
Protein kinase G inhibitor-1 |
|||
HY-48958 | MedChemExpress | 1 mg | EUR 476.2 |
Description: Protein kinase G inhibitor-1 (Compound 270) is a mycobacterial protein kinase G inhibitor, with an IC50 of 0.9 μM. Protein kinase G inhibitor-1 can be used for mycobacterial infection research[1]. |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1 kinase inhibitor 2 |
|||
HY-147785 | MedChemExpress | Get quote | Ask for price |
Description: Pim-1 kinase inhibitor 2 (Compound 13) is a potent inhibitor of Pim-1 kinase. Pim-1 kinase inhibitor 2 induces apoptosis. Pim-1 kinase inhibitor 2 has the potential for the research of cancer diseases[1]. |
Pim-1 kinase inhibitor 4 |
|||
HY-149976 | MedChemExpress | Get quote | Ask for price |
Description: Pim-1 kinase inhibitor 4 (Compound 10f) is a Pim-1 kinase inhibitor (IC50: 17.01 nM). Pim-1 kinase inhibitor 4 also has antioxidant activity and inhibits DPPH. Pim-1 kinase inhibitor 4 induces apoptosis in PC-3 cell, and inhibits PC-3 cell growth with an IC50 of 16 nM. Pim-1 kinase inhibitor 4 can be used for research of prostate cancer[1]. |
Pim-1 kinase inhibitor 5 |
|||
HY-149995 | MedChemExpress | Get quote | Ask for price |
Description: Pim-1 kinase inhibitor 5 (Compound 4c) is a Pim-1 kinase inhibitor (IC50: 0.61 μM). Pim-1 kinase inhibitor 5 shows cytotoxicity against cancer cells, with IC50s of 6.95-20.19 μM for HepG2, MCF-7, PC3, and HCT-116 cells[1]. |
Pim-1 kinase inhibitor 6 |
|||
HY-149996 | MedChemExpress | Get quote | Ask for price |
Description: Pim-1 kinase inhibitor 6 (Compound 4d) is a potent Pim-1 kinase inhibitor with IC50 value of 0.46 μM, and has significant cytotoxic effect on cancer cells[1]. |
Pim-1 kinase inhibitor 3 |
|||
HY-150731 | MedChemExpress | Get quote | Ask for price |
Description: Pim-1 kinase inhibitor 3 (Compound H5) is a potent Pim-1 kinase inhibitor with an IC50 of 35.13 nM[1]. |
Pim-1 kinase inhibitor 8 |
|||
HY-162006 | MedChemExpress | 10 mg | EUR 936.16 |
Description: Pim-1 kinase inhibitor 8 (compound 12) is a potent inhibitor of Pim-1 kinase with an IC50 of 14.3 nM. Pim-1 kinase inhibitor 8 has potent cytotoxicity against MCF-7 and HepG2 cells with IC50s of 0.5 and 5.27 μM, respectively. Pim-1 kinase inhibitor 8 can used in study breast cancer[1]. |
Pim-1 kinase inhibitor 10 |
|||
HY-162059 | MedChemExpress | Get quote | Ask for price |
Description: Pim-1 kinase inhibitor 10 (compound 13a) is a both competitive and non-competitive inhibitor of PIM-1/2 kinase. Pim-1 kinase inhibitor 10 can induce cell apoptosis and exhibits anticancer activity. Pim-1 kinase inhibitor 10 also induces caspase 3/7 activation[1]. |
Pim-1 kinase inhibitor 9 |
|||
HY-163119 | MedChemExpress | Get quote | Ask for price |
Description: Pim-1 kinase inhibitor 9 (compound 8b) is a selective inhibitor against Pim-1 kinase with IC50 value of 0.24 µM. Pim-1 kinase inhibitor 9 inhibits cell cycle of T47D at S phase. Pim-1 kinase inhibitor 9 reveals antitumor activity[1]. |
Pim-1 kinase inhibitor 3 |
|||
T61074-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 2 |
|||
T62001-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Pim-1 kinase inhibitor 2 |
Pan-RAF kinase inhibitor 1 |
|||
HY-142452 | MedChemExpress | Get quote | Ask for price |
Description: Pan-RAF kinase inhibitor 1 is a potent inhibitor of Pan-RAF kinase. Pan-RAF kinase inhibitor 1 regulates MAPK signaling by inhibiting RAF kinase, thereby exerting an effect on the proliferation of RAS-mutant tumor cells. Pan-RAF kinase inhibitor 1 has the potential for the research of cancer diseases (extracted from patent WO2021110141A1, compound 16B)[1]. |
Pan-RAF kinase inhibitor 1 |
|||
T63386-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Pan-RAF kinase inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
|||
HY-111752 | MedChemExpress | 10 mg | EUR 2759.78 |
Description: EML4-ALK kinase inhibitor 1 is a potent orally active inhibitor of echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK), with an IC50 of 1 nM[1]. |
Protein kinase D inhibitor 1 |
|||
HY-151372 | MedChemExpress | Get quote | Ask for price |
Description: Protein kinase D inhibitor 1 (compound 17m) is a pan-PKD inhibitor, with IC50 values ranging from 17 to 35 nM. Protein kinase D inhibitor 1 inhibits PKD-dependent cortactin phosphorylation[1]. |
EML4-ALK kinase inhibitor 1 |
|||
MBS5766584-10mg | MyBiosource | 10mg | EUR 700 |
EML4-ALK kinase inhibitor 1 |
|||
MBS5766584-1mg | MyBiosource | 1mg | EUR 280 |
EML4-ALK kinase inhibitor 1 |
|||
MBS5766584-25mg | MyBiosource | 25mg | EUR 1360 |
EML4-ALK kinase inhibitor 1 |
|||
MBS5766584-50mg | MyBiosource | 50mg | EUR 2065 |
EML4-ALK kinase inhibitor 1 |
|||
MBS5766584-5mg | MyBiosource | 5mg | EUR 420 |
EML4-ALK kinase inhibitor 1 |
|||
T11184-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: EML4-ALK kinase inhibitor 1 |
Multi-ancestry genome-wide affiliation examine identifies 27 loci related to measures of hemolysis following blood storage
The evolutionary strain of endemic malaria and different erythrocytic pathogens has formed variation in genes encoding erythrocyte structural and purposeful proteins, influencing responses to hemolytic stress throughout transfusion and illness.
We sought to determine such genetic variants in blood donors by conducting a genome-wide affiliation examine (GWAS) of 12,353 volunteer donors, together with 1,483 African People, 1,477 Asians, and 960 Hispanics, whose saved erythrocytes have been characterised by quantitative assays of in vitro osmotic, oxidative, and cold-storage hemolysis.
GWAS revealed 27 important loci (p<5×10-8), many in candidate genes identified to modulate erythrocyte construction, metabolism, and ion channels, together with SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/Band 3. GWAS of oxidative hemolysis recognized variants in antioxidant enzymes together with GLRX, GPX4, G6PD, and a novel golgi-transport protein SEC14L4.
Genome extensive important loci have been additionally examined for affiliation with the severity of regular state (baseline) in vivo hemolytic anemia in sufferers with sickle cell illness, with affirmation of recognized SNPs in HBA2, G6PD, PIEZO1, AQP1 and SEC14L4. Most of the recognized variants, equivalent to these in G6PD, have beforehand been proven to impair erythrocyte restoration after transfusion, affiliate with anemia, or trigger uncommon Mendelian human hemolytic illnesses.
Candidate SNPs in these genes, particularly in polygenic combos, could have an effect on RBC restoration after transfusion and modulate illness severity in hemolytic illnesses, equivalent to sickle cell illness and malaria.
Incorporating Genomic and Genetic Testing into the Therapy of Metastatic Luminal Breast Most cancers
Background: Therapy of sufferers with luminal metastatic breast most cancers (MBC) has turn out to be much more complicated over the previous few years as molecular profiling has begun to change illness administration. It’s properly accepted that MBC will not be curable however is treatable. Right now we’re capable of delay progression-free survival and partly total survival with focused and extra particular person therapy methods adjusted in keeping with the molecular subtype.
Abstract: Genetic and genomic testing has turn out to be therapeutically related in luminal MBC and is due to this fact an integral part inside the therapy spectrum. By now, germline testing of BRCABRCAPIK3CA mutations are inevitable parts in illness administration and the present state-of-the-art in luminal MBC sufferers.
Moreover, testing of ESR1 resistance mutation, ERBB2 mutation, microsatellite instability, and neurotrophic tyrosine receptor kinase (NTRK) gene fusion (primarily in secretory breast most cancers) has just lately gained growing consideration. Nonetheless, primarily based on the increasing function of personalised medication, clinicians are actually confronted with substantial new challenges and presumably unsuspected potentialities. The next evaluation summarizes present developments in genetic and genomic testing in luminal MBC.
Key messages: In luminal MBC genomics have turn out to be an integral part inside the spectrum of oncological therapy establishing novel therapeutic services. Additional developments in therapy personalization adjusted in keeping with the molecular subtype ought to turn out to be more and more necessary as a way to improve the progress of de-escalation of chemotherapy in luminal MBC. Nonetheless, primarily based on the increasing function of personalised medication, clinicians are actually confronted with substantial new challenges and presumably unsuspected potentialities.
HIV-1 p24 recombinant antigen. |
|||
MBS485187-5x1mg | MyBiosource | 5x1mg | EUR 5795 |
HIV Type 1 p24 Antigen ELISA 2.0 (96 Determinations) |
|||
0801002 | Cusabio | 96T | EUR 657.79 |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
HIV-P24 antigen array kit |
|||
VArk-Lsx001 | Creative Biolabs | unit | Ask for price |
Description: Fourth-generation HIV immunoassays detect viral p24 protein in the blood. |
HIV-1 gag p24 antigen (RECOMBINANT) |
|||
HI1A-720-4 | Austral Biologicals | 50ug | EUR 295 |
HIV-1 gag p24 antigen (RECOMBINANT) |
|||
HI1A-720-5 | Austral Biologicals | 100ug | EUR 495 |
Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit |
|||
abx257575-05mg | Abbexa | 0.5 mg | Ask for price |
Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit |
|||
abx257575-100g | Abbexa | 100 µg | EUR 468.75 |
Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit |
|||
abx257575-1mg | Abbexa | 1 mg | Ask for price |
Recombinant HIV-1 p24 Core Antigen |
|||
HIV-277 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
HIV-1 p17-p24 recombinant antigen. |
|||
00172-V | Virogen | 1 MG | EUR 850 |
HIV-1 p17-p24 recombinant antigen. |
|||
00172-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
Description: HIV-1 p17-p24 recombinant antigen. |
HIV-1 p17-p24 recombinant antigen. |
|||
MBS485154-01mg | MyBiosource | 0.1mg | EUR 300 |
HIV-1 p17-p24 recombinant antigen. |
|||
MBS485154-1mg | MyBiosource | 1mg | EUR 1300 |
HIV-1 p17-p24 recombinant antigen. |
|||
MBS485154-5x1mg | MyBiosource | 5x1mg | EUR 5795 |
Antibody against HIV P24 antigen |
|||
MBS478168-10mg | MyBiosource | 10mg | EUR 1560 |
Antibody against HIV P24 antigen |
|||
MBS478168-1mg | MyBiosource | 1mg | EUR 275 |
Antibody against HIV P24 antigen |
|||
MBS478168-20mg | MyBiosource | 20mg | EUR 2570 |
Antibody against HIV P24 antigen |
|||
MBS478168-50mg | MyBiosource | 50mg | EUR 6185 |
Antibody against HIV P24 antigen |
|||
MBS478168-5mg | MyBiosource | 5mg | EUR 840 |
Antibody against HIV P24 antigen |
|||
MBS478169-10mg | MyBiosource | 10mg | EUR 1560 |
Antibody against HIV P24 antigen |
|||
MBS478169-1mg | MyBiosource | 1mg | EUR 275 |
Antibody against HIV P24 antigen |
|||
MBS478169-20mg | MyBiosource | 20mg | EUR 2570 |
Antibody against HIV P24 antigen |
|||
MBS478169-50mg | MyBiosource | 50mg | EUR 6185 |
Antibody against HIV P24 antigen |
|||
MBS478169-5mg | MyBiosource | 5mg | EUR 840 |
Antibody against HIV P24 antigen |
|||
MBS478170-10mg | MyBiosource | 10mg | EUR 1560 |
Antibody against HIV P24 antigen |
|||
MBS478170-1mg | MyBiosource | 1mg | EUR 275 |
Antibody against HIV P24 antigen |
|||
MBS478170-20mg | MyBiosource | 20mg | EUR 2570 |
Antibody against HIV P24 antigen |
|||
MBS478170-50mg | MyBiosource | 50mg | EUR 6185 |
Antibody against HIV P24 antigen |
|||
MBS478170-5mg | MyBiosource | 5mg | EUR 840 |
Antibody against HIV P24 antigen |
|||
MBS478171-10mg | MyBiosource | 10mg | EUR 1560 |
Antibody against HIV P24 antigen |
|||
MBS478171-1mg | MyBiosource | 1mg | EUR 275 |
Antibody against HIV P24 antigen |
|||
MBS478171-20mg | MyBiosource | 20mg | EUR 2570 |
Antibody against HIV P24 antigen |
|||
MBS478171-50mg | MyBiosource | 50mg | EUR 6185 |
Antibody against HIV P24 antigen |
|||
MBS478171-5mg | MyBiosource | 5mg | EUR 840 |
HIV 1 p24 core recombinant antigen. |
|||
00177-V | Virogen | 1 MG | EUR 850 |
HIV 1 p24 core recombinant antigen |
|||
00177-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen |
|||
00177-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen. |
|||
00177-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
Description: HIV 1 p24 core recombinant antigen. |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV 1 p24 core recombinant antigen. |
|||
MBS485109-01mg | MyBiosource | 0.1mg | EUR 300 |
HIV 1 p24 core recombinant antigen. |
|||
MBS485109-1mg | MyBiosource | 1mg | EUR 1300 |
HIV 1 p24 core recombinant antigen. |
|||
MBS485109-5x1mg | MyBiosource | 5x1mg | EUR 5795 |
HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations) |
|||
801200 | Zeptometrix | 5 X 96 Determinations | EUR 2563 |
HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations) |
|||
0801200 | Zeptometrix | 5 X 96T | EUR 2563 |
Recombinant HIV-1 p24 Antigen, His-tagged |
|||
HIV-276 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
Recombinant HIV-1 p24 Antigen, His-tagged |
|||
HIV-281 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations) |
|||
0801008 | Zeptometrix | 5 X 96T | EUR 2505 |
Human HIV(1+2 antibodies plus p24 antigen (4th Generation) ELISA Kit |
|||
EH4101 | FN Test | 96T | EUR 571.5 |
Description: Method of detection: Qualitative ;Reacts with: Homo sapiens;Sensitivity: Qualitative |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947) |
|||
MAB12321-100 | The Native Antigen Company | 0.1 | EUR 278.11 |
Description: Mouse monoclonal antibody specific for HIV-1 p24 |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947) |
|||
MAB12321-500 | The Native Antigen Company | 0.5 | EUR 677.26 |
Description: Mouse monoclonal antibody specific for HIV-1 p24 |
HIV-1 gag p24 antigen IgG fraction (monoclonal) |
|||
HI1M-721-5 | Austral Biologicals | 100ug | EUR 425 |
Human Immunodeficiency Virus (HIV) p24 Antigen >95% |
|||
MBS568670-1mg | MyBiosource | 1mg | EUR 2175 |
Human Immunodeficiency Virus (HIV) p24 Antigen >95% |
|||
MBS568670-5x1mg | MyBiosource | 5x1mg | EUR 9585 |
Recombinant HIV-1 p24 Antigen, GST-tagged, HRP-Labled |
|||
HIV-282 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
Rat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614549-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3290 |
Rat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614549-48StripWells | MyBiosource | 48-Strip-Wells | EUR 295 |
Rat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614549-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1800 |
Rat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614549-96StripWells | MyBiosource | 96-Strip-Wells | EUR 450 |
Goat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614545-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3545 |
Goat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614545-48StripWells | MyBiosource | 48-Strip-Wells | EUR 310 |
Goat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614545-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1940 |
Goat HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614545-96StripWells | MyBiosource | 96-Strip-Wells | EUR 475 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
EIA06774h | Enlibio | each | EUR 430 |
Mouse HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614547-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3290 |
Mouse HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614547-48StripWells | MyBiosource | 48-Strip-Wells | EUR 295 |
Mouse HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614547-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1800 |
Mouse HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614547-96StripWells | MyBiosource | 96-Strip-Wells | EUR 450 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2602892-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3040 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2602892-48StripWells | MyBiosource | 48-Strip-Wells | EUR 285 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2602892-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1670 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2602892-96StripWells | MyBiosource | 96-Strip-Wells | EUR 405 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
NSL1389Hu | Sunlong | 96 wells | EUR 468 |
Description: Sandwich ELISA |
Bovine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2610168-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3545 |
Bovine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2610168-48StripWells | MyBiosource | 48-Strip-Wells | EUR 310 |
Bovine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2610168-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1940 |
Bovine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2610168-96StripWells | MyBiosource | 96-Strip-Wells | EUR 475 |
Canine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614543-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3545 |
Canine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614543-48StripWells | MyBiosource | 48-Strip-Wells | EUR 310 |
Canine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614543-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1940 |
Canine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614543-96StripWells | MyBiosource | 96-Strip-Wells | EUR 475 |
Rabbit HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614550-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3545 |
Rabbit HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614550-48StripWells | MyBiosource | 48-Strip-Wells | EUR 310 |
Rabbit HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614550-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1940 |
Rabbit HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614550-96StripWells | MyBiosource | 96-Strip-Wells | EUR 475 |
Chicken HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614544-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3545 |
Chicken HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614544-48StripWells | MyBiosource | 48-Strip-Wells | EUR 310 |
Chicken HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614544-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1940 |
Chicken HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614544-96StripWells | MyBiosource | 96-Strip-Wells | EUR 475 |
Porcine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614548-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3545 |
Porcine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614548-48StripWells | MyBiosource | 48-Strip-Wells | EUR 310 |
Porcine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614548-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1940 |
Porcine HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614548-96StripWells | MyBiosource | 96-Strip-Wells | EUR 475 |
Recombinant HIV-1 gag p17 and p24 Antigen, GST-tagged |
|||
PT2-332 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
Human Immunodeficiency Virus P24 Protein [HIV-1/Clade C] |
|||
REC31706-100 | The Native Antigen Company | 0.1 | EUR 457.08 |
Description: Recombinant HIV-1 p24 produced in E. coli with a 6x histidine tag. |
Human Immunodeficiency Virus P24 Protein [HIV-1/Clade C] |
|||
REC31706-500 | The Native Antigen Company | 0.5 | EUR 1167.82 |
Description: Recombinant HIV-1 p24 produced in E. coli with a 6x histidine tag. |
Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] |
|||
REC31743-100 | The Native Antigen Company | 0.1 | EUR 500.86 |
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells. |
Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] |
|||
REC31743-500 | The Native Antigen Company | 0.5 | EUR 1376.4 |
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells. |
HIV-1 p24 ELISA Kit |
|||
MBS412756-5x960Tests | MyBiosource | 5x960Tests | EUR 17580 |
HIV-1 p24 ELISA Kit |
|||
MBS412756-960Tests | MyBiosource | 960Tests | EUR 3770 |
HIV-1 p24 ELISA Kit |
|||
MBS412756-96Tests | MyBiosource | 96Tests | EUR 510 |
HIV-1 p24 ELISA Kit |
|||
Z7040001 | Biochain | 1 kit | EUR 771.8 |
Recombinant HIV-1 p24 gag Antigen, beta-galactosidase-tagged |
|||
HIV-278 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
Bovine HIV-1 p24 core protein(HIV-1 p24) Anti-body ELISA Kit |
|||
NSL1181Bo | Sunlong | 96 T | EUR 528 |
Description: Sandwich ELISA |
Guinea pig HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614546-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3545 |
Guinea pig HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614546-48StripWells | MyBiosource | 48-Strip-Wells | EUR 310 |
Guinea pig HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614546-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1940 |
Guinea pig HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
MBS2614546-96StripWells | MyBiosource | 96-Strip-Wells | EUR 475 |
Recombinant HIV-1 p24 Antigen, beta-galactosidase-tagged, Biotin-Labled |
|||
HIV-280 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
Recombinant HIV-1 gag p17-p24 and gp41-gp120 Antigen |
|||
VAC-0333 | Creative BioMart | 0.5ml | EUR 1598.4 |
Description: Protein |
OPEF01414-1MG - Recombinant Human Immunodeficiency Virus 1 (HIV 1-p24) Antigen |
|||
OPEF01414-1MG | Aviva Systems Biology | 1mg | EUR 2216 |
Recombinant HIV-1 gag p17, p24 and gp120 Antigen, GST-tagged |
|||
THP-0332 | Creative BioMart | 1 vial | EUR 2398.4 |
Description: Protein |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
EK11777 | SAB | 96Т | EUR 799 |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
AE62582HU-48T | Abebio | 48T | EUR 360 |
Description: Human (Homo sapiens) |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
AE62582HU-48Tests | Abebio | 48 Tests | EUR 360 |
Description: Human (Homo sapiens) |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
AE62582HU-96T | Abebio | 96T | EUR 680 |
Description: Human (Homo sapiens) |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
AE62582HU-96Tests | Abebio | 96 Tests | EUR 680 |
Description: Human (Homo sapiens) |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
MBS2800305-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6840 |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
MBS2800305-48StripWells | MyBiosource | 48-Strip-Wells | EUR 480 |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
MBS2800305-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3610 |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
MBS2800305-96StripWells | MyBiosource | 96-Strip-Wells | EUR 805 |
Human HIV (1+2) Antigen & Antibody ELISA Kit |
|||
MBS3802470-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Human HIV (1+2) Antigen & Antibody ELISA Kit |
|||
MBS3802470-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Human HIV (1+2) Antigen & Antibody ELISA Kit |
|||
MBS3802470-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Human HIV (1+2) Antigen & Antibody ELISA Kit |
|||
MBS3802470-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
00111-V | Virogen | 1 MG | EUR 850 |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
00111-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
MBS485158-01mg | MyBiosource | 0.1mg | EUR 300 |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
MBS485158-1mg | MyBiosource | 1mg | EUR 1300 |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
MBS485158-5x1mg | MyBiosource | 5x1mg | EUR 5795 |
Extended Range HIV-1 p24 ELISA Kit |
|||
MBS412758-5x96Samples | MyBiosource | 5x96Samples | EUR 2575 |
Extended Range HIV-1 p24 ELISA Kit |
|||
MBS412758-96Samples | MyBiosource | 96Samples | EUR 560 |
HIV-1 p24 (group O, strain BCF06) Antibody, Rabbit Pab, Antigen Affinity Purified |
|||
MBS8119499-002mL | MyBiosource | 0.02mL | EUR 185 |
HIV-1 p24 (group O, strain BCF06) Antibody, Rabbit Pab, Antigen Affinity Purified |
|||
MBS8119499-01mL | MyBiosource | 0.1mL | EUR 385 |
HIV-1 p24 (group O, strain BCF06) Antibody, Rabbit Pab, Antigen Affinity Purified |
|||
MBS8119499-5x01mL | MyBiosource | 5x0.1mL | EUR 1590 |
HIV-1 p17/24/gp120 antigen |
|||
00169-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. |
HIV-1 p17/24/gp120 antigen |
|||
00169-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. |
HIV-1 nef antigen |
|||
GWB-633F8F | GenWay Biotech | 0.5 mg | Ask for price |
HIV-1 gag p17 antigen (RECOMBINANT) |
|||
HI1A-710-4 | Austral Biologicals | 50ug | EUR 295 |
HIV-1 gag p17 antigen (RECOMBINANT) |
|||
HI1A-710-5 | Austral Biologicals | 100ug | EUR 495 |
HIV-1 gag p55 antigen (RECOMBINANT) |
|||
HI1A-730-4 | Austral Biologicals | 50ug | EUR 295 |
HIV-1 gag p55 antigen (RECOMBINANT) |
|||
HI1A-730-5 | Austral Biologicals | 100ug | EUR 495 |
HIV-1 p24 (HIV-1) |
|||
GWB-420F7B | GenWay Biotech | 0.1 mg | Ask for price |
Recombinant HIV-1 p55 gag Antigen |
|||
HIV-283 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
Recombinant HIV-1 p66 pol Antigen |
|||
HIV-284 | Creative BioMart | 1 vial | EUR 798.4 |
Description: Protein |
HIV-1 envelope p31 antigen (RECOMBINANT) |
|||
HI1A-700-4 | Austral Biologicals | 50ug | EUR 295 |
HIV-1 envelope p31 antigen (RECOMBINANT) |
|||
HI1A-700-5 | Austral Biologicals | 100ug | EUR 495 |
HIV-1 intergase antigen |
|||
00199-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). |
HIV-1 intergase antigen |
|||
00199-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). |
HIV-1 Recombinant antigen |
|||
MBS320616-01mg | MyBiosource | 0.1mg | EUR 440 |
HIV-1 Recombinant antigen |
|||
MBS320616-5x01mg | MyBiosource | 5x0.1mg | EUR 1885 |
HIV-1 Recombinant antigen |
|||
MBS320617-01mg | MyBiosource | 0.1mg | EUR 440 |
HIV-1 Recombinant antigen |
|||
MBS320617-5x01mg | MyBiosource | 5x0.1mg | EUR 1885 |
HIV-1 Recombinant antigen |
|||
MBS320618-01mg | MyBiosource | 0.1mg | EUR 630 |
HIV-1 Recombinant antigen |
|||
MBS320618-5x01mg | MyBiosource | 5x0.1mg | EUR 2745 |
HIV-1 (group M, subtype B, strain 92418) p24 Antibody, Rabbit PAb, Antigen Affinity Purified |
|||
MBS8105664-002mL | MyBiosource | 0.02mL | EUR 185 |
HIV-1 (group M, subtype B, strain 92418) p24 Antibody, Rabbit PAb, Antigen Affinity Purified |
|||
MBS8105664-01mL | MyBiosource | 0.1mL | EUR 385 |
HIV-1 (group M, subtype B, strain 92418) p24 Antibody, Rabbit PAb, Antigen Affinity Purified |
|||
MBS8105664-5x01mL | MyBiosource | 5x0.1mL | EUR 1590 |
HIV-1 p24 Antibody |
|||
20-abx137062 | Abbexa |
|
|
HIV-1 p24 Antibody |
|||
7313-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains. |
HIV-1 p24 Antibody |
|||
7313-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains. |
HIV-1 p24 Antibody |
|||
abx021869-1mg | Abbexa | 1 mg | EUR 794.4 |
HIV-1 p24 Antibody |
|||
abx021869-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021869-80l | Abbexa | 80 µl | EUR 937.5 |
HIV-1 p24 Antibody |
|||
abx021870-1mg | Abbexa | 1 mg | EUR 760.8 |
HIV-1 p24 Antibody |
|||
abx021871-1mg | Abbexa | 1 mg | EUR 794.4 |
HIV-1 p24 Antibody |
|||
abx021871-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021871-80l | Abbexa | 80 µl | EUR 937.5 |
HIV-1 p24 Antibody |
|||
abx021872-1mg | Abbexa | 1 mg | EUR 794.4 |
HIV-1 p24 Antibody |
|||
abx021872-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021872-80l | Abbexa | 80 µl | EUR 937.5 |
HIV-1 p24 Antibody |
|||
abx021873-1mg | Abbexa | 1 mg | EUR 794.4 |
HIV-1 p24 Antibody |
|||
abx021873-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021873-80l | Abbexa | 80 µl | EUR 937.5 |
HIV-1 p24 Antibody |
|||
abx021882-1mg | Abbexa | 1 mg | EUR 1178.4 |
HIV-1 p24 Antibody |
|||
abx021882-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021882-80l | Abbexa | 80 µl | EUR 1237.5 |
HIV-1 p24 Antibody |
|||
abx021883-1mg | Abbexa | 1 mg | EUR 1220.4 |
HIV-1 p24 Antibody |
|||
abx021883-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021883-80l | Abbexa | 80 µl | EUR 1237.5 |
HIV-1 p24 Antibody |
|||
abx021886-1mg | Abbexa | 1 mg | EUR 1220.4 |
HIV-1 p24 Antibody |
|||
abx021886-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021886-80l | Abbexa | 80 µl | EUR 1237.5 |
HIV-1 p24 Antibody |
|||
abx021887-1mg | Abbexa | 1 mg | EUR 1220.4 |
HIV-1 p24 Antibody |
|||
abx021887-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021887-80l | Abbexa | 80 µl | EUR 1587.5 |
HIV-1 p24 Antibody |
|||
abx021888-1mg | Abbexa | 1 mg | EUR 1220.4 |
HIV-1 p24 Antibody |
|||
abx021888-400l | Abbexa | 400 µl | Ask for price |
HIV-1 p24 Antibody |
|||
abx021888-80l | Abbexa | 80 µl | EUR 1237.5 |
HIV-1 p24 Antibody |
|||
abx023027-1ml | Abbexa | 1 ml | EUR 693.6 |